PURPOSE: Retinal dystrophy (RD) is a broad group of hereditary disorders with heterogeneous genotypes and phenotypes. Current available genetic testing for these diseases is complicated, time consuming, and expensive. This study was conducted to develop and apply a microarray-based, high-throughput resequencing system to detect sequence alterations in genes related to inherited RD. METHODS: A customized 300-kb resequencing chip, Retina-Array, was developed to detect sequence alterations of 267,550 bases of both sense and antisense sequence in 1470 exons spanning 93 genes involved in inherited RD. Retina-Array was evaluated in 19 patient samples with inherited RD provided by the eyeGENE repository and four Centre d'Etudes du Polymorphisme Humaine reference samples through a high-throughput experimental approach that included an automated PCR assay setup and quantification, efficient post-quantification data processing, optimized pooling and fragmentation, and standardized chip processing. RESULTS: The performance of the chips demonstrated that the average base pair call rate and accuracy were 93.56% and 99.86%, respectively. In total, 304 candidate variations were identified using a series of customized screening filters. Among 174 selected variations, 123 (70.7%) were further confirmed by dideoxy sequencing. Analysis of patient samples using Retina-Array resulted in the identification of 10 known mutations and 12 novel variations with high probability of deleterious effects. CONCLUSIONS: This study suggests that Retina-Array might be a valuable tool for the detection of disease-causing mutations and disease severity modifiers in a single experiment. Retinal-Array may provide a powerful and feasible approach through which to study genetic heterogeneity in retinal diseases.
PURPOSE:Retinal dystrophy (RD) is a broad group of hereditary disorders with heterogeneous genotypes and phenotypes. Current available genetic testing for these diseases is complicated, time consuming, and expensive. This study was conducted to develop and apply a microarray-based, high-throughput resequencing system to detect sequence alterations in genes related to inherited RD. METHODS: A customized 300-kb resequencing chip, Retina-Array, was developed to detect sequence alterations of 267,550 bases of both sense and antisense sequence in 1470 exons spanning 93 genes involved in inherited RD. Retina-Array was evaluated in 19 patient samples with inherited RD provided by the eyeGENE repository and four Centre d'Etudes du Polymorphisme Humaine reference samples through a high-throughput experimental approach that included an automated PCR assay setup and quantification, efficient post-quantification data processing, optimized pooling and fragmentation, and standardized chip processing. RESULTS: The performance of the chips demonstrated that the average base pair call rate and accuracy were 93.56% and 99.86%, respectively. In total, 304 candidate variations were identified using a series of customized screening filters. Among 174 selected variations, 123 (70.7%) were further confirmed by dideoxy sequencing. Analysis of patient samples using Retina-Array resulted in the identification of 10 known mutations and 12 novel variations with high probability of deleterious effects. CONCLUSIONS: This study suggests that Retina-Array might be a valuable tool for the detection of disease-causing mutations and disease severity modifiers in a single experiment. Retinal-Array may provide a powerful and feasible approach through which to study genetic heterogeneity in retinal diseases.
Authors: D J Cutler; M E Zwick; M M Carrasquillo; C T Yohn; K P Tobin; C Kashuk; D J Mathews; N A Shah; E E Eichler; J A Warrington; A Chakravarti Journal: Genome Res Date: 2001-11 Impact factor: 9.043
Authors: Baochuan Lin; Zheng Wang; Gary J Vora; Jennifer A Thornton; Joel M Schnur; Dzung C Thach; Kate M Blaney; Adam G Ligler; Anthony P Malanoski; Jose Santiago; Elizabeth A Walter; Brian K Agan; David Metzgar; Donald Seto; Luke T Daum; Russell Kruzelock; Robb K Rowley; Eric H Hanson; Clark Tibbetts; David A Stenger Journal: Genome Res Date: 2006-02-15 Impact factor: 9.043
Authors: Md Nawajes A Mandal; John R Heckenlively; Tracy Burch; Lianchun Chen; Vidyullatha Vasireddy; Robert K Koenekoop; Paul A Sieving; Radha Ayyagari Journal: Invest Ophthalmol Vis Sci Date: 2005-09 Impact factor: 4.799
Authors: Katy Downs; David N Zacks; Rafael Caruso; Athanasios J Karoukis; Kari Branham; Beverly M Yashar; Mark H Haimann; Karmen Trzupek; Meira Meltzer; Delphine Blain; Julia E Richards; Richard G Weleber; John R Heckenlively; Paul A Sieving; Radha Ayyagari Journal: Arch Ophthalmol Date: 2007-02
Authors: Anirban Maitra; Yoram Cohen; Susannah E D Gillespie; Elizabeth Mambo; Noriyoshi Fukushima; Mohammad O Hoque; Nila Shah; Michael Goggins; Joseph Califano; David Sidransky; Aravinda Chakravarti Journal: Genome Res Date: 2004-05 Impact factor: 9.043
Authors: Lori S Sullivan; Sara J Bowne; Melissa J Reeves; Delphine Blain; Kerry Goetz; Vida Ndifor; Sally Vitez; Xinjing Wang; Santa J Tumminia; Stephen P Daiger Journal: Invest Ophthalmol Vis Sci Date: 2013-09-19 Impact factor: 4.799
Authors: Li Zhao; Feng Wang; Hui Wang; Yumei Li; Sharon Alexander; Keqing Wang; Colin E Willoughby; Jacques E Zaneveld; Lichun Jiang; Zachry T Soens; Philip Earle; David Simpson; Giuliana Silvestri; Rui Chen Journal: Hum Genet Date: 2014-12-04 Impact factor: 4.132
Authors: Mark B Consugar; Daniel Navarro-Gomez; Emily M Place; Kinga M Bujakowska; Maria E Sousa; Zoë D Fonseca-Kelly; Daniel G Taub; Maria Janessian; Dan Yi Wang; Elizabeth D Au; Katherine B Sims; David A Sweetser; Anne B Fulton; Qin Liu; Janey L Wiggs; Xiaowu Gai; Eric A Pierce Journal: Genet Med Date: 2014-11-20 Impact factor: 8.822
Authors: Daniel F Schorderet; Alexandra Iouranova; Tatiana Favez; Leila Tiab; Pascal Escher Journal: Biomed Res Int Date: 2012-12-26 Impact factor: 3.411